Literature DB >> 7559394

CrmA, a poxvirus-encoded serpin, inhibits cytotoxic T-lymphocyte-mediated apoptosis.

M Tewari1, W G Telford, R A Miller, V M Dixit.   

Abstract

Cytotoxic T-lymphocytes (CTLs), by virtue of their ability to recognize and induce apoptotic death of virus-infected cells, comprise a major antiviral defense mechanism. The induction of apoptosis by CTLs can be completely accounted for by two mechanisms: (i) a Ca(2+)-dependent component that involves the exocytotic release of serine proteases known as granzymes from CTL granules and their subsequent insertion into the target cell to induce apoptosis and (ii) a Ca(2+)-independent component that involves the activation of Fas, a receptor on the target cell membrane that triggers apoptosis. Although viruses have evolved several indirect mechanisms for evading the CTL response, direct inhibition of the apoptotic cascade has never been described. We now show for the first time that the cowpox virus protein CrmA, a protease inhibitor of the serpin family, is capable of inhibiting CTL-mediated cytolysis. The inhibitory effect is largely the result of blockade of the Ca(2+)-independent (i.e. Fas-mediated) component of CTL killing. CrmA thus represents the first example of a viral gene product capable of directly blocking CTL-mediated cell death.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7559394     DOI: 10.1074/jbc.270.39.22705

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Creation of killer poxvirus could have been predicted.

Authors:  A Müllbacher; M Lobigs
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

2.  Regions of the herpes simplex virus type 1 latency-associated transcript that protect cells from apoptosis in vitro and protect neuronal cells in vivo.

Authors:  Maryam Ahmed; Martin Lock; Cathie G Miller; Nigel W Fraser
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  Subcellular localization of CrmA: identification of a novel leucine-rich nuclear export signal conserved in anti-apoptotic serpins.

Authors:  Jose A Rodriguez; Simone W Span; Frank A E Kruyt; Giuseppe Giaccone
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

4.  Two newly characterized germinal center B-cell-associated genes, GCET1 and GCET2, have differential expression in normal and neoplastic B cells.

Authors:  Zenggang Pan; Yulei Shen; Cheng Du; Guimei Zhou; Andreas Rosenwald; Louis M Staudt; Timothy C Greiner; Timothy W McKeithan; Wing C Chan
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

5.  A functional role for death proteases in s-Myc- and c-Myc-mediated apoptosis.

Authors:  S Kagaya; C Kitanaka; K Noguchi; T Mochizuki; A Sugiyama; A Asai; N Yasuhara; Y Eguchi; Y Tsujimoto; Y Kuchino
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

6.  Vaccinia virus F1L protein is a tail-anchored protein that functions at the mitochondria to inhibit apoptosis.

Authors:  Tara L Stewart; Shawn T Wasilenko; Michele Barry
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

7.  Host response to the attenuated poxvirus vector NYVAC: upregulation of apoptotic genes and NF-kappaB-responsive genes in infected HeLa cells.

Authors:  Susana Guerra; Luis A López-Fernández; Alberto Pascual-Montano; José Luis Nájera; Angel Zaballos; Mariano Esteban
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

8.  Maspin mediates increased tumor cell apoptosis upon induction of the mitochondrial permeability transition.

Authors:  Khatri Latha; Weiguo Zhang; Nathalie Cella; Heidi Y Shi; Ming Zhang
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

Review 9.  Divergence towards a dead end? Cleavage of the divergent domains of ribosomal RNA in apoptosis.

Authors:  G Houge; S O Døskeland
Journal:  Experientia       Date:  1996-10-31

Review 10.  Regulation of apoptosis by viral gene products.

Authors:  J G Teodoro; P E Branton
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.